Investors

  • 2022-05-23
    NOTIFICATION LETTER WITH CHANGE REQUEST FORM TO REGISTERED SHAREHOLDERS
  • 2022-05-23
    FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, 29 JUNE 2022
  • 2022-05-23
    NOTICE OF ANNUAL GENERAL MEETING
  • 2022-05-23
    PROPOSED RE-ELECTION OF DIRECTORS; GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-APPOINTMENT OF RETIRING AUDITOR; ADOPTION OF NEW ARTICLES OF ASSOCIATION; GRANT OF 2021 SHARE AWARDS, 2022 SHARE AWARDS AND PERFORMANCE TARGET AWARDS TO CONNECTED PERSONS; INCREASE IN SCHEME LIMIT UNDER THE POST-IPO SHARE AWARD SCHEME; SCHEME MANDATE TO ISSUE SHARES UNDER THE POST-IPO SHARE AWARD SCHEME; AND NOTICE OF AGM
  • 2022-05-06
    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2022
  • 2022-04-08
    NOTIFICATION LETTER TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF 2021 ANNUAL REPORT AND REQUEST FORM FOR NON-REGISTERED HOLDERS
  • 2022-04-08
    NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2021 ANNUAL REPORT AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS
  • 2022-04-08
    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2022
  • 2022-04-01
    (1) GRANT OF OPTIONS, (2) GRANT OF AWARDS, (3) NON-EXEMPT CONNECTED TRANSACTIONS — PROPOSED AWARD GRANT TO CONNECTED PERSONS, (4) NON-EXEMPT CONNECTED TRANSACTIONS — PROPOSED PERFORMANCE TARGET AWARD GRANT TO CONNECTED PERSONS, (5) INCREASE IN ANNUAL LIMIT UNDER THE POST-IPO SHARE AWARD SCHEME, (6) PROPOSED INCREASE IN SHARE AWARD SCHEME LIMIT UNDER THE POST-IPO SHARE AWARD SCHEME, AND (7) PROPOSED SCHEME MANDATE TO ISSUE SHARES UNDER THE POST-IPO SHARE AWARD SCHEME
  • 2022-03-30
    NEXT DAY DISCLOSURE RETURN
 Copyright Everest Medicines 2020  云顶药业(苏州)有限公司 苏ICP备20038571号 |  Terms of Use |  Privacy Policy |  Disclaimers

沪公网安备 31010602006477号